Terapia builds 38m-euro plant in Cluj

Terapia Ranbaxy drug producer, owned by India’s Ranbaxy group, plans to start building a new drug production facility in Cluj-Napoca in 2013, with investments amounting to 50m dollars (around 38m euros).
The greenfield project will be developed on a six hectare area owned by the Cluj-based company and the construction of the plant will last for around one year.
Terapia plans to start production in the new facility in 2014, so that by late 2015 the company’s production capacity should increase by 50%.
The drugs to be manufactured in the new facility will be used for the treatment of cancer, HIV-AIDS or cardiovascular illnesses. Also, the company plans to hire between 200 and 300 persons in the next three years, to be added to the current 800.
“(…) Whereas at present we manufacture 2 billion packs of finite products, in five years we want to reach a capacity of 3 billion packs,” Dragoș Damian, general manager of Ranbaxy Terapia, told ZF Transilvania.
He did not provide any additional information on the source of funds needed to carry out this project.